1350113-04-0
1350113-04-0
Chemical Structure
YGZ-331
- CAS No.: 1350113-04-0
- Formula:C19H23N5O4
- Molecular Weight:385.42
InChIKey: RRRLUFHDFDNPMZ-BPAMBQHCSA-N
SMILES: OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C=NC3=C2N=CN=C3N[C@H](C4=CC=CC=C4)CC)O1
Biological Activity: YGZ-331 is a sedative with a calming effect. YGZ-331 is a derivative of the adenosine nucleoside NGBA, which can increase GABA levels. YGZ-331 exerts a sedative-hypnotic effect by activating A1R and A2aR, and inhibiting CaMKII phosphorylation (pCaMKII) levels. YGZ-331 can reduce the spontaneous motor activity of mice[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
YGZ-331 | YGZ-331 is a sedative with a calming effect. YGZ-331 is a derivative of the adenosine nucleoside NGBA, which can increase GABA levels. YGZ-331 exerts a sedative-hypnotic effect by activating A1R and A2aR, and inhibiting CaMKII phosphorylation (pCaMKII) levels. YGZ-331 can reduce the spontaneous motor activity of mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
